Takeda Pharmaceuticals America, Inc.
Takeda Pharmaceuticals America, Inc. is listed as the manufacturer on 12 FDA drug label records covering 12 distinct active ingredients predominantly human prescription drug products.
About Takeda Pharmaceuticals America, Inc.
Takeda Pharmaceuticals America, Inc. is named as the labeler on 12 FDA drug label records. Its catalogue spans 12 distinct active ingredients, led by ALOGLIPTIN AND METFORMIN HYDROCHLORIDE, CARBAMAZEPINE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: patients years, weight loss, type diabetes, attention deficit, hyperactivity disorder, newly diagnosed, clinical studies, higher plasma. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 10 |
| — | — | SUBCUTANEOUS | 2 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Takeda Pharmaceuticals America, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Actoplus Met | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Adderall XR | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE | HUMAN PRESCRIPTION DRUG | ORAL |
| Carbatrol | CARBAMAZEPINE | HUMAN PRESCRIPTION DRUG | ORAL |
| ENTYVIO | VEDOLIZUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Fruzaqla | FRUQUINTINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Iclusig | PONATINIB HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| KAZANO | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| MIMRYLO | RUSFERTIDE | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| MYDAYIS | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE | HUMAN PRESCRIPTION DRUG | ORAL |
| NINLARO | IXAZOMIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Rozerem | RAMELTEON | HUMAN PRESCRIPTION DRUG | ORAL |
| Vyvanse | LISDEXAMFETAMINE DIMESYLATE | HUMAN PRESCRIPTION DRUG | ORAL |
Frequently asked questions
How many FDA drug products does Takeda Pharmaceuticals America, Inc. make?
12 FDA drug label records name Takeda Pharmaceuticals America, Inc. as the manufacturer, covering 12 distinct active ingredients.
What active ingredients does Takeda Pharmaceuticals America, Inc. produce?
The most frequent active ingredients in this portfolio are ALOGLIPTIN AND METFORMIN HYDROCHLORIDE, CARBAMAZEPINE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FRUQUINTINIB.
Are Takeda Pharmaceuticals America, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.